Linsitinib
CAS No. 867160-71-2
Linsitinib ( ASP-7487;ASP 7487;OSI-906;OSI906 )
Catalog No. M16302 CAS No. 867160-71-2
Linsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 30 | In Stock |
|
5MG | 47 | In Stock |
|
10MG | 67 | In Stock |
|
25MG | 106 | In Stock |
|
50MG | 151 | In Stock |
|
100MG | 210 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLinsitinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLinsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively.
-
DescriptionLinsitinib (ASP-7487, OSI-906) is a potent, selective, orally active, dual IGF-1R/insulin receptor inhibitor with IC50 of 35/75 nM, respectively; potently and selectively inhibits autophosphorylation of both human IGF-1R and IR, displays in vitro antiproliferative effects in a variety of tumor cell lines and shows robust in vivo anti-tumor efficacy in an IGF-1R-driven xenograft model.Liver Cancer Phase 3 Clinical
-
SynonymsASP-7487;ASP 7487;OSI-906;OSI906
-
PathwayAngiogenesis
-
TargetIGF-1R
-
RecptorIGF-1R;InsulinReceptor;IRR
-
Research AreaCancer
-
IndicationLiver Cancer
Chemical Information
-
CAS Number867160-71-2
-
Formula Weight421.49
-
Molecular FormulaC26H23N5O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO[C@@]1(C)C[C@H](C2=NC(C3=CC=C4C=CC(C5=CC=CC=C5)=NC4=C3)=C6C(N)=NC=CN62)C1
-
Chemical NameCyclobutanol, 3-[8-amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-, cis-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Mulvihill MJ, et al. Future Med Chem. 2009 Sep;1(6):1153-71.
2. Pitts TM, et al. Clin Cancer Res. 2010 Jun 15;16(12):3193-204.
3. Buck E, et al. Mol Cancer Ther. 2010 Oct;9(10):2652-64.
4. Kuhn DJ, et al. Blood. 2012 Oct 18;120(16):3260-70.
2. Pitts TM, et al. Clin Cancer Res. 2010 Jun 15;16(12):3193-204.
3. Buck E, et al. Mol Cancer Ther. 2010 Oct;9(10):2652-64.
4. Kuhn DJ, et al. Blood. 2012 Oct 18;120(16):3260-70.
molnova catalog
related products
-
HNMPA
HNMPA is an inhibitor of insulin receptor tyrosine kinase and inhibits the serine and tyrosine autophosphorylation of human insulin receptor.
-
NVP-AEW541
NVP-AEW541 (AEW-541, AEW541) is a potent, and selective inhibitor of IGF-1R with IC50 of 86 nM.
-
Insulin(human)
Insulin(human) is a polypeptide hormone that regulates the level of glucose.